A. Van Oosterom

A phase II trial with rosiglitazone in liposarcoma patients

Guy Debrock, V Vanhentenrijk, Raf Sciot et al. · British Journal of Cancer · 2003 · 158 citations · Full text

Medicine, Oncology, Pharmacology +15

Thrombopoietic effects and toxicity of interleukin-6 in patients with ovarian cancer before and after chemotherapy: a multicentric placebo- controlled, randomized phase Ib study

Véronique D’Hondt, Yves Humblet, T. Guillaume et al. · Blood · 1995 · 97 citations · Full text

Medicine, Gynecology, Oncology +17

Microvessel quantification in primary colorectal carcinoma: an immunohistochemical study

P. Vermeulen, Didier Verhoeven, H. Fierens et al. · British Journal of Cancer · 1995 · 77 citations

Medicine, Oncology, Pathology +16

EORTC (30885) randomised phase III study with recombinant interferon alpha and recombinant interferon alpha and gamma in patients with advanced renal cell carcinoma

PHM de Mulder, G.O.N. Oosterhof, C Bouffioux et al. · British Journal of Cancer · 1995 · 70 citations · Full text

Medicine, Oncology, Urologic Oncology +7

Doxorubicin vs epirubicin, report of a second-line randomized phase II/III study in advanced breast cancer

M. Bontenbal, Maria Andersson, J. Wildiers et al. · British Journal of Cancer · 1998 · 56 citations · Full text

Medicine, Oncology, Pharmacology +12